Researchers at New York University have devised a mathematical approach to predict the structures of crystals—a critical step in developing many medicines and electronic devices—in a matter of ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Pinterest's Q3 update showed strong fundamentals with 11% user growth and 18% revenue growth, yet the stock fell 16%. Read ...

Medifast's strong quarterly performance, investments in growth strategies, and undervalued stock make it an attractive ...

Third Quarter 2024 Results Key Financial Results Revenue: US$140.2m (down 41% from 3Q 2023).

Fintel reports that on November 5, 2024, DA Davidson upgraded their outlook for Medifast (NYSE:MED) from Underperform to ...

Medifast ( (MED) ) has released its Q3 earnings. Here is a breakdown of the information Medifast presented to its investors. Medifast (NYSE: ...

For the current quarter ending in December, Medifast expects its per-share earnings to range from 10 cents to 65 cents. The company said it expects revenue in the range of $100 million to $120 million ...

Reports Q3 revenue $140.163M vs $235.869M last year. “Medical innovation has transformed the weight loss industry, so at Medifast (MED) ...

Wellness company Medifast (NYSE:MED) will be reporting results tomorrow after market hours. Here’s what investors should know ...

Medifast, Inc. MED is likely to register a decrease in both top and bottom lines when it reports third-quarter 2024 earnings on Nov. 4. The Zacks Consensus Estimate for revenues is pegged at $135. ...